Highlights from ASH 2023 in Transplant-Eligible NDMM
January 15th 2024Experts in multiple myeloma discuss highlights from the ASH 2023 meeting around transplant-eligible NDMM with particular focus on the PERSEUS and GRIFFIN trials and the clinical implications of the results of these studies.
Read More